Breaking News
November 19, 2017 - Dental filling failure linked to smoking, drinking and genetics
November 19, 2017 - Medicaid expansion takes a bite out of medical debt
November 19, 2017 - Study aims to involve parents in early intervention services for children with autism
November 19, 2017 - Don’t Fret Delays in Treating Colon Cancer, Study Suggests
November 19, 2017 - Yeast Infection Test: MedlinePlus Lab Test Information
November 19, 2017 - Video of blood clot contraction reveals how platelets naturally form unobtrusive clots
November 19, 2017 - UNN researchers explore modeling of cognitive dissonance phenomenon
November 19, 2017 - Verseon presents second anticoagulation candidate for clinical trials at AHA 2017
November 19, 2017 - Pregnant Asian women who develop high blood pressure at highest risk for heart failure hospitalization
November 19, 2017 - Medicare seeks comment on ways to cut costs of Part D drugs
November 19, 2017 - Tree cover linked to fewer asthma cases in polluted urban neighborhoods
November 19, 2017 - Make the Diagnosis: Hair Care Conundrum
November 19, 2017 - New techniques give blood biopsies greater promise
November 19, 2017 - Researchers identify possible genetic basis for coronary artery disease
November 19, 2017 - Stress experienced by emergency call handlers has negative impact on psychological health
November 18, 2017 - New cancer cell screening is improving childhood leukaemia treatment
November 18, 2017 - Groundbreaking study identifies protein as potential factor in cancer metastasis
November 18, 2017 - New model to test effectiveness of existing and potential CF therapies
November 18, 2017 - Staying Active May Lower Odds for Glaucoma
November 18, 2017 - Potential new autism drug shows promise in mice
November 18, 2017 - Some states roll back ‘retroactive Medicaid,’ a buffer for the poor — and for hospitals
November 18, 2017 - Selectively deleting stem cell factor promotes recovery after TBI in mice
November 18, 2017 - Breakthrough research brings new procedure closer to helping patients with blood cancer
November 18, 2017 - Dr Peter Simpson Appointed to SLAS Board of Directors
November 18, 2017 - Friendships between young children can protect against ADHD
November 18, 2017 - Old World monkeys could hold key to stop progression of rheumatoid arthritis
November 18, 2017 - Harris Health System RNs named among 20 Outstanding Nurses for 2017
November 18, 2017 - Old World monkeys could be key to a new, powerful rheumatoid arthritis therapy
November 18, 2017 - Mount Sinai researchers identify new therapeutic target for ER+ breast cancer
November 18, 2017 - Age, CRP levels predict success in tapering of biologics in rheumatoid arthritis patients
November 18, 2017 - New dye could be used to observe electrical activity of neurons in the brain
November 18, 2017 - New study further validates use of vaginal progesterone to decrease risk of preterm birth
November 18, 2017 - Russian researcher determined range of reference values for boron in the human body
November 18, 2017 - ‘What the Health?’ Tax bill or health bill?
November 18, 2017 - Could Your Cat Give You ‘Bird Flu?’
November 18, 2017 - Vitamin D Linked to Fertility Outcomes in ART
November 18, 2017 - Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer’s disease
November 18, 2017 - Tax reform proposal could impact care for older Americans
November 18, 2017 - PCSK9 inhibitor offers clinical benefit to patients with peripheral artery disease
November 18, 2017 - Researchers receive £1.3 million to develop sight-saving imaging technology
November 18, 2017 - Novel buckypaper sensor could pave way for high-performance, affordable wearable technology
November 18, 2017 - Despite ACA cost protections, most adolescents skip regular checkups
November 18, 2017 - Stem cell treatment allows paraplegic rats to walk and regain sensory perception
November 18, 2017 - HTC analytical conference comes to the UK
November 18, 2017 - Face It: Drinking, Smoking Takes Toll on Looks: MedlinePlus Health News
November 18, 2017 - New research shows where in the brain the earliest signs of Alzheimer’s occur
November 18, 2017 - Philips announces launch of global movement to raise awareness for COPD
November 18, 2017 - University of Bristol awarded grant to reduce antibacterial drug resistance in Thailand
November 18, 2017 - New oxytocin chemical sensor could be first step towards early diagnosis of autism
November 18, 2017 - Study shows how naïve T-cells may affect tumor immunity and immunotherapy
November 18, 2017 - New studies highlight importance of cardiorespiratory fitness to reduce CVD risk
November 18, 2017 - Study finds medical cannabis is effective at reducing opioid addiction
November 18, 2017 - Specially tailored, ultrafast light pulses can trigger neurons to fire in different patterns
November 18, 2017 - Decrease in sunshine linked to rising incidence of Rickets
November 18, 2017 - Harnessing social media big data to fight against prescription drug crisis
November 18, 2017 - Researchers find way to switch tumor cells between 2D and 3D morphology
November 18, 2017 - Leaf-eating ability of beetle largely due to bacteria inside the insect
November 18, 2017 - FDA Approves Hemlibra (emicizumab-kxwh) for Hemophilia A with Inhibitors
November 18, 2017 - Adolescents underreport amphetamine use, likely unaware that adderall is amphetamine
November 18, 2017 - Study reveals a reduced risk of teenage eczema in breastfed babies
November 18, 2017 - Separating side effects could pave way for safe, effective pain medications
November 18, 2017 - Gut bacteria at young age can contribute to MS disease onset and progression, study suggests
November 18, 2017 - Environmental triggers may play role in development of Lupus
November 18, 2017 - Review looks into conventional versus new treatment modalities in orthodontic pain management
November 17, 2017 - FDA Alert: Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall
November 17, 2017 - For older women, every movement matters
November 17, 2017 - Talking-based therapy could transform aftercare for cancer survivors
November 17, 2017 - Olympus IXplore SpinSR10 imaging system enables researchers to observe fine details in live cells
November 17, 2017 - Study explores reasons for underrepresentation of minorities in genetic cancer research
November 17, 2017 - California firm running physician practices is closing down as scrutiny ramps up
November 17, 2017 - BMI not valid measure of obesity in postmenopausal women, study shows
November 17, 2017 - Vaginal progesterone decreases the risk of premature birth in women with short cervix
November 17, 2017 - Pricey ER Tests for Chest Pain Often Unnecessary
November 17, 2017 - ‘Old’ Lungs May Be Good Transplant Options: MedlinePlus Health News
November 17, 2017 - How not to gain weight over the holidays
November 17, 2017 - Researchers map first-ever proteome of healthy human heart
November 17, 2017 - Drug used to prevent and treat malaria may also be effective for Zika virus
November 17, 2017 - One in 20 children still receiving codeine to treat pain despite warning from federal regulators
November 17, 2017 - Improving clinical trials with machine learning
November 17, 2017 - Experts identify mental exercise program that can reduce risk of dementia
Fecal Occult Blood Test (FOBT): MedlinePlus Lab Test Information

Fecal Occult Blood Test (FOBT): MedlinePlus Lab Test Information

image_pdfDownload PDFimage_print

What is a Fecal Occult Blood Test?

A fecal occult blood test (FOBT) looks at a sample of your stool (feces) to check for blood. Occult blood means that you can’t see it with the naked eye. Blood in the stool means there is likely some kind of bleeding in the digestive tract. It may be caused by a variety of conditions, including:

Blood in the stool may also be a sign of colorectal cancer, a type of cancer that starts in the colon or rectum. Colorectal cancer is the second leading cause of cancer-related deaths in the United States and the third most common cancer in men and in women. A fecal occult blood test is a screening test that may help find colorectal cancer early, when treatment is most effective.

Other names: FOBT, stool occult blood, occult blood test, Hemoccult test, guaiac smear test, gFOBT, immunochemical FOBT, iFOBT; FIT

What is it used for?

A fecal occult blood test is used as an early screening test for colorectal cancer. It may also be used to diagnose other conditions that cause bleeding in the digestive tract.

Why do I need a fecal occult blood test?

The National Cancer Institute recommends that people get regular screenings for colorectal cancer starting at age 50. The screening may be a fecal occult test, a colonoscopy, or another test. Talk with your health care provider about which test is right for you.

If you choose a fecal occult blood test, you need to get it every year. If you have a colonoscopy, you only need it every ten years. But it is a more invasive procedure. You may need screening more often if you have certain risk factors. These include:

What happens during a fecal occult blood test?

A fecal occult blood test is a noninvasive test that you can perform at home at your convenience. Your health care provider will give you a kit that includes instructions on how to do the test. There are two main types of fecal occult blood tests: the guaiac smear method (gFOBT) and the immunochemical method (iFOBT or FIT). Below are typical instructions for each test. Your instructions may vary slightly depending on the manufacturer of the test kit.

For a guaiac smear test (gFOBT), you will most likely need to:

  • Collect samples from three separate bowel movements.
  • For each sample, collect the stool and store in a clean container. Make sure the sample does not mix in with urine or water from the toilet.
  • Use the applicator from your test kit to smear some of the stool on the test card or slide, also included in your kit.
  • Label and seal all your samples as directed.
  • Mail the samples to your health care provider or lab.

For a fecal immunochemical test (FIT), you will most likely need to:

  • Collect samples from two or three bowel movements.
  • Collect the sample from the toilet using the special brush or other device that was included in your kit.
  • For each sample, use the brush or device to take the sample from the surface of the stool.
  • Brush the sample onto a test card.
  • Label and seal all your samples as directed.
  • Mail the samples to your health care provider or lab.

Be sure to follow all the instructions provided in your kit, and talk to your health care provider if you have any questions.

Will I need to do anything to prepare for the test?

Certain foods and drugs may affect the results of a guaiac smear method (gFOBT) test. Your health care provider may ask you to avoid the following:

  • Nonsteroidal, anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen, or aspirin for seven days prior to your test. If you take aspirin for heart problems, talk to your health care provider before stopping your medicine. Acetaminophen may be safe to use during this time, but check with your health care provider before taking it.
  • More than 250 mg of vitamin C daily from supplements, fruit juices, or fruit for seven days prior to your test. Vitamin C can affect the chemicals in the test and cause a negative result even if there is blood present.
  • Red meat, such as beef, lamb, and pork, for three days prior to the test. Traces of blood in these meats may cause a false-positive result.

There are no special preparations or dietary restrictions for a fecal immunochemical test (FIT).

Are there any risks to the test?

There is no known risk to having a fecal occult blood test.

What do the results mean?

If your results are positive for either type of fecal occult blood test, it means you likely have bleeding somewhere in your digestive tract. But it does not necessarily mean you have cancer. Other conditions that may produce a positive result on a fecal occult blood test include ulcers, hemorrhoids, polyps, and benign tumors. If your test results are positive for blood, your health care provider will likely recommend additional testing, such as a colonoscopy, to figure out the exact location and cause of your bleeding. If you have questions about your results, talk to your health care provider.

Is there anything else I need to know about a fecal occult blood test?

Regular colorectal cancer screenings, such as the fecal occult blood test, are an important tool in the fight against cancer. Studies show that screening tests can help find cancer early, and may reduce deaths from the disease.

Tagged with:

About author

Related Articles